Company Filing History:
Years Active: 2025
Title: Sandra Uhlenbroich: Innovator in Cancer Treatment
Introduction
Sandra Uhlenbroich is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biomedical research, particularly in the development of specific binding members for therapeutic applications. Her work focuses on innovative solutions for treating cancer and infectious diseases.
Latest Patents
Sandra holds 1 patent for her invention titled "Fc binding fragments comprising an OX40 antigen-binding site." This patent relates to specific binding members that target OX40, a crucial component in the immune response. The binding members are designed to be utilized in therapies aimed at combating cancer and various infectious diseases.
Career Highlights
Throughout her career, Sandra has worked with notable companies, including Invox Pharma Limited and Bicycletx Limited. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative treatments.
Collaborations
Sandra has collaborated with talented individuals in her field, including Mihriban Tuna and Miguel Gaspar. These partnerships have enriched her research and expanded the impact of her work.
Conclusion
Sandra Uhlenbroich is a dedicated inventor whose work in developing OX40-targeting therapies showcases her commitment to advancing medical science. Her contributions are paving the way for new treatment options in oncology and infectious disease management.